KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astrana Health (ASTH) Gross Profit (2016 - 2025)

Astrana Health's Gross Profit history spans 16 years, with the latest figure at $97.2 million for Q3 2025.

  • For Q3 2025, Gross Profit rose 32.25% year-over-year to $97.2 million; the TTM value through Sep 2025 reached $297.0 million, up 14.27%, while the annual FY2024 figure was $271.4 million, 26.25% up from the prior year.
  • Gross Profit for Q3 2025 was $97.2 million at Astrana Health, up from $78.0 million in the prior quarter.
  • Across five years, Gross Profit topped out at $97.2 million in Q3 2025 and bottomed at $23.3 million in Q4 2021.
  • The 5-year median for Gross Profit is $55.3 million (2023), against an average of $58.4 million.
  • The largest annual shift saw Gross Profit crashed 41.38% in 2021 before it skyrocketed 76.64% in 2022.
  • A 5-year view of Gross Profit shows it stood at $23.3 million in 2021, then soared by 76.64% to $41.1 million in 2022, then dropped by 5.13% to $39.0 million in 2023, then grew by 29.5% to $50.5 million in 2024, then skyrocketed by 92.54% to $97.2 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Gross Profit are $97.2 million (Q3 2025), $78.0 million (Q2 2025), and $71.3 million (Q1 2025).